The Neuroprotective Effects of RPC on the Neurosurgery
Clinical Trial Cencer, Xijing Hospital, Fourth Military Medical University
1 other identifier
interventional
70
0 countries
N/A
Brief Summary
The current study is designed to clarify the neuroprotective effect of remote ischemic precondtioning on the patients underwent neurosurgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Sep 2008
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2008
CompletedFirst Submitted
Initial submission to the registry
March 19, 2009
CompletedFirst Posted
Study publicly available on registry
March 20, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2009
CompletedDecember 28, 2010
March 1, 2009
9 months
March 19, 2009
December 26, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
S-100b and NSE level
7 days
Study Arms (2)
sham RIPC
NO INTERVENTIONPatients had a deflated cuff placed on the right upper arm for 30 min.
RIPC
EXPERIMENTALRIPC consisted of three 5-min cycles of right upper arm ischemia, which was induced by an automated cuff-inflator placed on the right upper arm and inflated to 200 mmHg, with an intervening 5 min of reperfusion during which the cuff was deflated
Interventions
Remote ischemic preconditioning consist of three 5-min cycles of right upper limb ischaemia, induced by an automated cuff-inflator placed on the upper arm and inflated to 200 mm Hg, with an intervening 5 min of reperfusion during which the cuff is deflated.
Eligibility Criteria
You may qualify if:
- Patients referred for primary elective neurosurgery were invited to participate in the study at the time of scheduling for operation
You may not qualify if:
- Potential participants were excluded if they were \>70 years of age
- Required concomitant procedures other than neurosurgery
- Had experienced an acute coronary syndrome or myocardial infraction within 3 months
- Were unable to give informed consent
- Were taking sulfonylurea oral hypoglycemic agents or nicorandil drug therapy because these agents have been shown to effect preconditioning.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Xijing Hospitallead
Study Officials
- PRINCIPAL INVESTIGATOR
Hailong DONG, M.D.,Ph.D.
Xijing Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
March 19, 2009
First Posted
March 20, 2009
Study Start
September 1, 2008
Primary Completion
June 1, 2009
Study Completion
September 1, 2009
Last Updated
December 28, 2010
Record last verified: 2009-03